Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Removal of Doravirine by Hemodialysis in HIV-Infected Patients with End-Stage Renal Disease
2020-004454-30Phase 4Completed
- Sponsor
- Fight AIDS and Infectious Diseases Foundation
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of doravirine in human immunodeficiency virus infection (HIV) and end-stage kidney disease (ESKD), sponsored by Fight AIDS and Infectious Diseases Foundation. Primary endpoint: Hemodialysis extraction ratio for doravirine. Started Nov 2020; status: completed.
02
Drugs
doravirine
03
Conditions
human immunodeficiency virus infection (HIV)end-stage kidney disease (ESKD)
Beyond the preview
Go deeper on 2020-004454-30.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-004454-30.